Back to search
FDAFDA · Food and drugs·Recall number Z-2927-2026

Thermo Fisher Diagnostics Neisseria meningitidis Gp C 2ml/VL, Product Number R30166901; invitro diagnostics

Published August 19, 2026 · Recall initiated: July 17, 2026

Summary

FDA records medical device Class II recall Z-2927-2026, published August 19, 2026 and initiated July 17, 2026. Recalling firm: Remel Europe Ltd.; Status: Ongoing; Reported quantity: 26 units; Lot: UDI/DI 05056080501161, Lot Numbers: 6214791, exp. 18/03/2025; 6175327, exp. 04/12/2027; 6148809, exp. 30/09/2027; 6002010, exp. 31/07/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Certain lots of Neisseria meningitidis Gp C 2ml/VL, R30166901, are not performing to IFU criteria not positive to ATCC13102 within 60 Seconds.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Remel Europe Ltd.
Distributor
US Nationwide distribution.
Lot
UDI/DI 05056080501161, Lot Numbers: 6214791, exp. 18/03/2025; 6175327, exp. 04/12/2027; 6148809, exp. 30/09/2027; 6002010, exp. 31/07/2027.
Risk classification
Class II
Area (FDA)
device
Country
United Kingdom

Related recalls

Questions about this recall

Was Thermo Fisher Diagnostics Neisseria meningitidis Gp C 2ml/VL, Product Number R30166901; invitro diagnostics recalled?

Yes. FDA published recall Z-2927-2026 on August 19, 2026. Reported hazard: Certain lots of Neisseria meningitidis Gp C 2ml/VL, R30166901, are not performing to IFU criteria not positive to ATCC13102 within 60 Seconds.

What should I do if I have this product?

Voluntary: Firm initiated · Letter